Ariad Pharmaceuticals Inc. buy phonebroker
Start price
17.01.14
/
50%
€5.21
Target price
03.02.14
€7.00
Performance (%)
2.92%
End price
03.02.14
€5.36
Summary
This prediction ended on 03.02.14 with a price of €5.36. The BUY prediction by phonebroker finished with a performance of 2.92%. phonebroker has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Ariad Pharmaceuticals Inc. | - | - | - | - |
iShares Core DAX® | -0.079% | -3.039% | 13.992% | 14.646% |
iShares Nasdaq 100 | 0.247% | 6.421% | 36.232% | 55.769% |
iShares Nikkei 225® | 1.918% | 0.675% | 10.784% | 5.212% |
iShares S&P 500 | 0.146% | 4.708% | 29.832% | 48.430% |
Comments by phonebroker for this prediction
In the thread Ariad Pharmaceuticals Inc. diskutieren
Ariad weiter auf Erholungskurs
Der Absturz vom August letzten Jahres scheint allmählich abgearbeitet. Der Optimismus gewinnt die Oberhand. Dazu passt die News: ARIAD Announces Commercial Availability of Iclusig for Patients with Refractory Philadelphia-Positive Leukemias in US.
Read more: http://www.benzinga.com/news/14/01/4231301/ariad-announces-commercial-availability-of-iclusig-for-patients-with-refractory-p#ixzz2qfniyVvl
(Stop Loss Kurs erreicht)
Stopped prediction by phonebroker for Ariad Pharmaceuticals Inc.
Ariad Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.90
26.03.16
26.03.16
€9.02
01.04.16
01.04.16
-3.82%
01.04.16
01.04.16
Ariad Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€3.75
11.10.13
11.10.13
€10.00
18.10.13
18.10.13
-43.01%
18.10.13
18.10.13
Ariad Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€19.38
06.10.12
06.10.12
€25.00
02.01.13
02.01.13
-21.80%
02.01.13
02.01.13